A detailed history of Rappaport Reiches Capital Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Rappaport Reiches Capital Management, LLC holds 366 shares of LLY stock, worth $290,655. This represents 0.09% of its overall portfolio holdings.

Number of Shares
366
Previous 275 33.09%
Holding current value
$290,655
Previous $249 Million 30.28%
% of portfolio
0.09%
Previous 0.07%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024

BUY
$772.14 - $960.02 $70,264 - $87,361
91 Added 33.09%
366 $325 Million
Q2 2024

Jul 18, 2024

SELL
$724.87 - $909.04 $6,523 - $8,181
-9 Reduced 3.17%
275 $249 Million
Q1 2024

Apr 16, 2024

BUY
$592.2 - $792.28 $168,184 - $225,007
284 New
284 $221 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $755B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Rappaport Reiches Capital Management, LLC Portfolio

Follow Rappaport Reiches Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rappaport Reiches Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rappaport Reiches Capital Management, LLC with notifications on news.